Alpha Tau Medical (DRTS) Return on Capital Employed (2022 - 2026)

Alpha Tau Medical has disclosed Return on Capital Employed across 5 years of filings, most recently posting 47.84% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 47.84%, down 219.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 47.84% (down 219.0% YoY), and the FY2025 annual result was 49.51%, up 860.0% from the prior year.
• Return on Capital Employed came in at 47.84% for Q1 2026 at Alpha Tau Medical, up from 44.67% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 50.04% in Q1 2025 to a low of 20.52% in Q2 2022.
• The 5-year median for Return on Capital Employed is 36.21% (2024), against an average of 36.05%.
• Across the five-year window, Return on Capital Employed jumped 1382 bps in 2025 and sank 219 bps in 2026, its largest moves.
• Alpha Tau Medical's Return on Capital Employed stood at 27.84% in 2022, then advanced by 28 bps to 35.76% in 2023, then gained by 26 bps to 45.17% in 2024, then retreated by 1 bps to 44.67% in 2025, then advanced by 7 bps to 47.84% in 2026.
• The last three Return on Capital Employed figures came in at 47.84% (Q1 2026), 44.67% (Q4 2025), and 40.49% (Q3 2025), per Business Quant data.